NO20076426L - Aktiv sammensetning for behandling eller for a unnga problemer relatert til forstyrrelse av den biologiske klokken - Google Patents

Aktiv sammensetning for behandling eller for a unnga problemer relatert til forstyrrelse av den biologiske klokken

Info

Publication number
NO20076426L
NO20076426L NO20076426A NO20076426A NO20076426L NO 20076426 L NO20076426 L NO 20076426L NO 20076426 A NO20076426 A NO 20076426A NO 20076426 A NO20076426 A NO 20076426A NO 20076426 L NO20076426 L NO 20076426L
Authority
NO
Norway
Prior art keywords
disturbance
treatment
active composition
biological clock
problems related
Prior art date
Application number
NO20076426A
Other languages
English (en)
Inventor
Jean-Christophe Anton
Original Assignee
Persee Medica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Persee Medica filed Critical Persee Medica
Publication of NO20076426L publication Critical patent/NO20076426L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3486—Humulus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Oppfinnelsen er relatert til en aktiv sammensetning for behandling eller forebygging av problemer forårsaket ved en forstyrrelse av den biologiske klokken i mennesker og omfattende polyumettede fettsyrer og flavonoider som aktive ingredienser.
NO20076426A 2005-05-13 2007-12-13 Aktiv sammensetning for behandling eller for a unnga problemer relatert til forstyrrelse av den biologiske klokken NO20076426L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0551254A FR2885528A1 (fr) 2005-05-13 2005-05-13 Composition utile pour traiter ou prevenir les troubles lies a un dereglement de l'horloge biologique
PCT/FR2006/001079 WO2006120360A2 (fr) 2005-05-13 2006-05-12 Composition pour traiter ou prevenir les troubles liés à un dérèglement de l'horloge biologique

Publications (1)

Publication Number Publication Date
NO20076426L true NO20076426L (no) 2008-02-08

Family

ID=35423717

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076426A NO20076426L (no) 2005-05-13 2007-12-13 Aktiv sammensetning for behandling eller for a unnga problemer relatert til forstyrrelse av den biologiske klokken

Country Status (7)

Country Link
US (1) US20090069425A1 (no)
EP (1) EP1879621A2 (no)
CA (1) CA2608060A1 (no)
EA (1) EA200702479A1 (no)
FR (1) FR2885528A1 (no)
NO (1) NO20076426L (no)
WO (1) WO2006120360A2 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3485894B1 (en) * 2017-11-20 2021-01-06 Italfarmaco SpA Combination of officinal plants and their use in the treatment and/or prevention of sleep disorders
JP2020031570A (ja) * 2018-08-29 2020-03-05 大正製薬株式会社 体内時計調整用組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851431A (en) * 1986-11-26 1989-07-25 Bar Ilan University Physiologically active and nutritional composition
US20020068100A1 (en) * 2000-10-12 2002-06-06 Bioriginal Food & Science Corporation Combination therapy for premenstrual symptoms
FR2815227B1 (fr) * 2000-10-17 2003-04-11 Schwartz Laboratoires Robert Composition anti-stress destinee a etre incorporee principalement a des vehicules nutritionnels
US6391346B1 (en) * 2001-04-05 2002-05-21 Thomas Newmark Anti-inflammatory, sleep-promoting herbal composition and method of use
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
US7258922B2 (en) * 2003-03-31 2007-08-21 Thi International, Inc. Compositions, methods and devices for enhancing landscaping or marker materials
DE10255481A1 (de) * 2002-11-28 2004-06-17 Dr. Loges + Co. Gmbh Arzneimittel Pharmazeutische Zubereitungen umfassend mittels Extraktion mit überkritischen Flüssigkeiten hergestellte Hopfenextrakte zur Verwendung als Sedativa
DE10315025A1 (de) * 2003-04-02 2004-10-14 Bioplanta Arzneimittel Gmbh Wirkstoffkombination von ω3-fettsäurehaltigen Ölen mit polyphenolhaltigen Pflanzenextrakten und deren Verwendung

Also Published As

Publication number Publication date
WO2006120360A2 (fr) 2006-11-16
WO2006120360A3 (fr) 2007-11-08
CA2608060A1 (fr) 2006-11-16
EP1879621A2 (fr) 2008-01-23
FR2885528A1 (fr) 2006-11-17
EA200702479A1 (ru) 2008-04-28
US20090069425A1 (en) 2009-03-12

Similar Documents

Publication Publication Date Title
BRPI0613358A8 (pt) ácidos de gordura poli - insaturada para o tratamento da demência e condições relacionadas à pré-demência
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
ECSP10010735A (es) Compuestos químicos 251
NO20074647L (no) 3,4 dihydro-1H-isoquinolin-2-karboksylsyre-5-ammopyridin-2-yl estere
EA200700382A1 (ru) Фунгицидные композиции
EA200870019A1 (ru) Лактамовые соединения и способы их применения
FR2927254B1 (fr) Utilisation de substances actives naturelles dans des compositions cosmetiques ou therapeutiques
CL2007003452A1 (es) Metodo para prevenir enfermedades de plantas causadas por microorganismos, fitopatogenos, que comprende aplicar la quinolina 3-(5-fluor-3,3-dimetil-3,4-dehidroisoquinolin-1-il)quinolina en tratamiento directo a las semillas.
NO20083780L (no) Topisk sammensetning omfattende en antibakteriell substans
NO20070561L (no) Sammensetninger og fremgangsmater for a behandle oyesykdommer og tilstander.
BRPI0607402A2 (pt) uso de inibidores de pde7 para o tratamento de dor neuropática
BRPI0516645A (pt) composições de perfume
ATE509624T1 (de) Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
BRPI0609393B8 (pt) usos de um composto 11-desóxi-prostaglandina
EP1906772A4 (en) TREATMENT OF ROOT VEGETABLES
CL2007003802A1 (es) Compuestos derivados de piperidina, inhibidores de la sintasa de acidos grasos; procedimiento de preparacion de dichos compuestos; y su uso para tratar la obesidad o el sobrepeso.
FR2892623B1 (fr) Composition cosmetique comprenant un cation, un corps gras solide et un ester de sorbitan et procede de traitement cosmetique
WO2008002571A3 (en) Human protein tyrosine phosphatase inhibitors and methods of use
NO20064584L (no) Tetrahydropyridoindolderivater
NO20074318L (no) Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer
EA201071293A1 (ru) Композиция для укладки волос
NO20090334L (no) DHA-estere og anvendelse derav i behandling og forebygging av kordiovaskulaer sykdom
NO20061625L (no) Behandling og/eller forhindring av urininkontinens ved bruk av prolegemidler av gaba analoger
MX336452B (es) Complejo aclarador de la piel, uso del complejo, composicion cosmetica o farmaceutica que comprende el complejo y metodo para su aplicacion.
DE602005007188D1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application